Prior authorization follow-up referral brief template: a fill-in handoff with a completed example

Short answer

A company introduction about prior authorization follow-up needs eight core facts, plus one line each on the task and the record classes: company size and role, the systems that hold the history, years covered, rough annual volume of pended requests, who owns the records, who can authorize a licensing discussion, when access to the old platform ends, and the one open question about the evidence. Leave out every patient, member, payer contract and clinical detail. The revenue cycle director should be able to forward it unchanged.

Visual briefFull-size diagram
A blank referral brief card with eight fields, company size, role, systems, years held, annual pends, record owner, decision-maker and access date, filling in one by one with Illustrative values, and a footer noting that no patient or member detail is included.
Illustrative values for a fictional revenue cycle company; the brief carries metadata only.

This template is part of the prior authorization follow-up guide. Copy the blank, fill it in during one conversation with the director, then compare it with the completed example below.

The blank brief

Copy this table into an email or document. Every row describes metadata: what exists, how much, how long, where and who.

FieldWhat to writeNever include
CompanyFull-time headcount at peak, role (provider group or revenue cycle company), countryClient or patient names
Business taskOne line on the follow-up work: pend received, document found, resubmitted, decision chasedAny individual request
Record classesWhich kinds exist: each request as sent and resent, payer asks for more paperwork, decisions with reasons, internal task notes, a log of what each payer requiresThe records themselves
SystemsSoftware names or types, plus any fax server or electronic transaction vendor; flag the one being replacedLogins, exports, screenshots
Years and volumeYears of closed requests per system; approximate pended requests per yearPatient counts by payer or service
Record ownerThe role that manages the history day to dayPersonal contact details beyond the work email
Decision-makerThe executive who can approve a data discussion, plus the privacy officerOpinions on value or price
Access eventDate old platform access ends, or "not set"Vendor contract terms
Open questionOne general question about whether the evidence chain survivesA specific case

Filling it in with the revenue cycle director

Most rows take one question each. A few need care.

Company. Count full-time employees at peak and leave contractors out; offshore authorization teams staffed by a vendor do not count toward the 50.

Record classes. Ask which kinds exist, not which are complete. A director may know that resent requests are kept but not whether every attachment travelled with them. Write what is known and mark the rest unconfirmed.

Systems. Name each tool once. Electronic requests follow the HIPAA standard transaction for prior authorization, so an outside transaction vendor may be involved; list it separately, because its retention follows its own contract, not the company's.

Years and volume. Separate the current platform from anything already retired. A director often knows the live system's depth but forgets the history sitting in a system switched off years ago, which may still be readable.

Role. For a billing company, add how many provider clients the history covers. HHS guidance says a business associate may use or disclose protected health information only as permitted or required by its business associate contract or as required by law, so the count tells the decision-maker how much agreement review lies ahead.

Decision-maker. If the director hesitates, the who-can-license decision tree walks through who can say yes.

Open question. Phrase it about the chain, not a patient. A useful one: when a payer changed a requirement after the first submission, does the record keep the link between version one, the pend and version two?

Completed brief (Illustrative)

Illustrative only. The company and every figure are fictional.

FieldEntry
Company230 full-time employees at peak; multi-specialty provider group running its own authorizations; U.S.
Business taskChasing pended imaging and surgical authorizations from pend to payer decision
Record classesRequest versions with attachments, payer document requests, decisions with reasons, payer requirement log
SystemsPractice management system with authorization module; fax server; electronic transactions through a clearinghouse
Years and volumeNine years in the current system, two more in a retired one; roughly 14,000 pended requests a year
Record ownerAuthorization supervisor, reporting to the director of patient access
Decision-makerChief operating officer, with the privacy officer; director of patient access as sponsor
Access eventNot set; the practice management vendor contract renews in 2027
Open questionWhen a payer asked for a new document after the first request, can the reply be tied back to the original request?
Not sharedNo patient, member, payer contract or clinical detail; no exports or logins

Notice what the example does not say: nothing about price, nothing about what an AI lab might want, nothing about any patient. It gives the chief operating officer enough to decide whether a conversation is worth an hour.

Covering note and what happens next

Two or three sentences are enough above the table: who you are, why the access date matters, and that the company keeps control of every record. The warm introduction brief and warm introduction etiquette cover tone, and the client opportunity brief generator can draft a first version.

After the executive reads it, SourceX reviews qualification, rights and de-identification. As they stand the records are protected health information, so any licensed version would need to meet HIPAA's de-identification standard by Expert Determination or Safe Harbor. SourceX licenses approved business data directly from companies for AI training and evaluation, and manages the agreement, rights review, data preparation, delivery and payout. Buyer interest, the rights result and any offer stay unknown until that review. The systems map for this workflow helps if the director wants to check which identifiers join the records first.

For SourceX, an introduced company needs 50+ full-time employees at peak (contractors excluded), a documented operating history, rights to license and an authorized contact. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 90% of the data is in English. Partners sign the Channel Partner Agreement before submitting introductions; the first valid introduction within the 90-day window is credited when the company submits a verified application. Sector context sits under revenue cycle management firms and healthcare operations.

Next step

Refer a company. Earn up to $100,000. Default reward: 25% of Actual Supplier Payout, capped at $100,000 cumulatively per referred company. Eligibility and payment conditions apply, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

With every row of the brief filled in or honestly marked unknown, register as a partner, confirm the company on who qualifies and read the program terms before the director forwards it.

  1. Step 1Share your linkSend your personal link to a company you know.
  2. Step 2Company appliesThe company applies itself at /apply.
  3. Step 3Company signs and is paidThe company signs, delivers its data and is paid by SourceX under its agreement.
  4. Step 4You get your rewardYour 25% of the actual supplier payout. A reward becomes payable after SourceX has paid the referred company under its signed agreement and the payout conditions in the program terms are met, including finance approval and your tax and payment details.

Common questions

Can I attach a sample authorization to make the brief concrete?

No. Even one request carries protected health information. The brief describes record classes, counts and systems; the open question is phrased in general terms, never as a specific patient's case.

What if the director does not know the annual volume?

Write an order of magnitude the director is comfortable with, or write unknown. A guessed precise number does more harm than an honest blank, because SourceX will check it during review.

Who should receive the brief?

The revenue cycle director forwards it to the executive named in the decision-maker field. The partner keeps a copy and submits the same facts when registering the introduction.

Sources

  1. cms.gov/priorities/key-initiatives/burden-reduction/…
  2. hhs.gov/hipaa/for-professionals/privacy/guidance/bus…
  3. hhs.gov/hipaa/for-professionals/special-topics/de-id…
  4. refer.sourcex.si/terms

Free resources

Know a company with valuable proprietary data?

Become a referral partner, get your link and introduce the company’s CEO (in an owner-run company, usually the owner). Referral partners can join from most countries. We can't work with partners in countries or regions under U.S. sanctions or on U.S. restricted-party lists. The companies you introduce should be based in the U.S., Canada and the EU, or in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia with at least 90% of their data in English.

Refer a company →

I own a business

Explore licensing your company's data directly to SourceX for AI training and evaluation. Start a short assessment; no uploads needed.

Start an assessment